Sedation with remazolam and remifentanil for sepsis patients
Treatments studied
Part of Infections clinical trials.
This study tests a combination of two sedative drugs (remazolam besylate and remifentanil) for calming patients with sepsis who are on a ventilator in the ICU. The goal is to see if this approach improves recovery compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have sepsis and be on a breathing machine (ventilator) in the ICU.
- You must be expected to stay in the ICU for at least 2 days.
- You must be able to have light sedation (RASS score between -2 and 0).
- You or your family must agree to take part in the study (sign a consent form).
- You cannot be pregnant or breastfeeding.
- You cannot have severe liver disease or kidney failure needing dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This trial compares two types of sedation for older adults recovering from heart bypass surgery in the ICU. It aims to see which drug keeps your heart function more stable while you are on a breathing machine.
This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.
This study tests whether a sedative medication called remimazolam helps patients on breathing machines (ventilators) in the ICU recover better and have fewer complications. You would receive this medication to keep you calm and comfortable while on the ventilator.
This trial compares two sedative medications, remimazolam and midazolam, to see which works better and is safer for deeply sedating adults on breathing machines who have unstable blood pressure. It may help doctors choose a sedation option that causes fewer drops in blood pressure.
This study compares two sedation medicines—remimazolam vs midazolam—for very sick ICU patients who are on a breathing machine. It looks at whether one sedative works better or is safer for keeping patients comfortable while they’re critically ill.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.